Company Monitoring Page for Roche

latest headlines for company on cafepharma

The ‘don’t eat me’ antidote: GlaxoSmithKline, Roche and Novo back $86M startup in high-stakes CD47 showdown
Endpoints
Tue, 08/16/16 - 11:16 am
Tags:
GSK, Roche, Novo Nordisk, Tioma Therapeutics, CD47, immuno-oncology
As doubts continue to fester, Inovio gets another shove as Roche exits collaboration
Endpoints
Wed, 08/3/16 - 10:09 am
Tags:
Roche, Inovio, INO-1800, INO-5150, hepatitis B
Hey, wait a second. What about Roche’s PhIII hemophilia A drug?
Endpoints
Fri, 07/29/16 - 11:24 am
Tags:
Roche, hemophilia A, Chugai, emicizumab, ACE910
A Look at Roche’s Potential Revenue Drivers
Market Realist
Tue, 07/26/16 - 11:21 am
Tags:
Roche, Perjeta, Herceptin, Kadcyla
Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict
Fierce Pharma
Mon, 07/25/16 - 11:20 am
Tags:
Roche, Accutane
Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai
Fierce Biotech
Fri, 07/22/16 - 11:47 am
Tags:
Galderms, atopic dermatitis, Roche, Chugai, nemolizumab
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Tags:
Amgen, Allergan, biosimilars, Herceptin, ABP 980, Roche, breast cancer
Roche sales buoyed by cancer drugs
BioPharma Dive
Thu, 07/21/16 - 09:15 pm
Tags:
Roche, earnings
Late-stage study of Roche's Gazyva in large B-cell lymphoma fails to hit main goal
First Word Pharma
Mon, 07/18/16 - 10:55 am
Tags:
Roche, Gazyva, large B-cell lymphoma, clinical trials
The 15 top R&D spenders in the global biopharma business
Endpoints
Fri, 07/15/16 - 10:23 am
Tags:
R&D, Roche, JNJ, Novartis, Pfizer, Merck, Bristol-Myers Squibb
BioMarin Pharmaceutical shares rise after possible takeover from Roche
CNBC
Thu, 07/7/16 - 04:02 pm
Tags:
Biomarin, M&A, Roche
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Sat, 07/2/16 - 12:28 pm
Tags:
Bayer, Abbott Labs, Novo Nordisk, Roche, Merck
Epizyme partners with Roche to test cancer drug combo
BioPharma Dive
Thu, 06/23/16 - 08:22 pm
Tags:
Epizyme, Roche, PDL-1 inhibitors, diffuse large B-cell lymphoma, Tecentriq, tazemetostat
Pharm Exec's Top 50 Companies 2016
PharmExec
Thu, 06/16/16 - 03:27 pm
Tags:
Pfizer, Novartis, Roche, Merck, Sanofi, Gilead Sciences, JNJ, GSK
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Tue, 06/7/16 - 12:11 pm
Tags:
public opinion, reputation, Bayer, Abbott Labs, Novo Nordisk, Roche
Drug makers pay $67m for misleading docs about cancer drug survival data
Stat
Mon, 06/6/16 - 11:21 pm
Tags:
Roche, Genentech, OSI Pharmaceuticals, False Claims Act, whistleblower lawsuits, Tarceva, non-small cell lung cancer
How Mylan Is Taking On One of the World's Top Breast Cancer Drugs
Fortune
Mon, 06/6/16 - 10:36 am
Tags:
Roche, breast cancer, Herceptin, biosimilars, Mylan Labs
New Roche med Tecentriq shines in study of untreated bladder cancer patients
Fierce Pharma
Sun, 06/5/16 - 11:52 am
Tags:
Roche, Tecentriq, bladder cancer, ASCO 2016
Five Storylines To Watch At ASCO
Forbes
Tue, 05/31/16 - 11:14 am
Tags:
ASCO 2016, drug pricing, Pfizer, Ibrance, breast cancer, Tecentriq, Genentech, Roche, PDL-1 inhibitors
Roche's Hematology Franchise Almost 100% Protected From Biosimilars
Seeking Alpha
Fri, 05/27/16 - 10:59 pm
Tags:
Roche, hematology, biosimilars, Gazyva, Rituxan

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.